JP2002029965A - 親水性または塩の形態よりなる薬物を含有する経皮投与用製剤 - Google Patents

親水性または塩の形態よりなる薬物を含有する経皮投与用製剤

Info

Publication number
JP2002029965A
JP2002029965A JP2001181939A JP2001181939A JP2002029965A JP 2002029965 A JP2002029965 A JP 2002029965A JP 2001181939 A JP2001181939 A JP 2001181939A JP 2001181939 A JP2001181939 A JP 2001181939A JP 2002029965 A JP2002029965 A JP 2002029965A
Authority
JP
Japan
Prior art keywords
preparation
drug
adhesive base
weight
transdermal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001181939A
Other languages
English (en)
Japanese (ja)
Inventor
Wan Suk Lee
ワン スク リー
Young Dae Lee
ヤング ダエ リー
Jung Ju Kim
ジュング ジュ キム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacific Corp
Original Assignee
Pacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Corp filed Critical Pacific Corp
Publication of JP2002029965A publication Critical patent/JP2002029965A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2001181939A 2000-06-16 2001-06-15 親水性または塩の形態よりなる薬物を含有する経皮投与用製剤 Pending JP2002029965A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR2000-33330 2000-06-16
KR20000033330 2000-06-16

Publications (1)

Publication Number Publication Date
JP2002029965A true JP2002029965A (ja) 2002-01-29

Family

ID=19672297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001181939A Pending JP2002029965A (ja) 2000-06-16 2001-06-15 親水性または塩の形態よりなる薬物を含有する経皮投与用製剤

Country Status (6)

Country Link
US (1) US20020012695A1 (de)
EP (1) EP1163902B1 (de)
JP (1) JP2002029965A (de)
KR (1) KR100433614B1 (de)
CN (1) CN1171583C (de)
DE (1) DE60126017T2 (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005170833A (ja) * 2003-12-10 2005-06-30 Nichiban Co Ltd 経皮吸収型貼付剤
JP2006151927A (ja) * 2004-12-01 2006-06-15 Toin Gakuen 光線力学的治療用組成物
WO2007119656A1 (ja) * 2006-04-11 2007-10-25 Nichiban Co., Ltd. タムスロシン含有経皮吸収型製剤
JP2007536312A (ja) * 2004-05-07 2007-12-13 アンタレス ファルマ イーペーエル アクチェンゲゼルシャフト 抗コリン作用薬のための透過性増強組成物
JP2009280509A (ja) * 2008-05-20 2009-12-03 Kowa Co 鎮痛・抗炎症剤含有外用剤
JP2010053078A (ja) * 2008-08-28 2010-03-11 Teika Seiyaku Kk オキシコドン経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤
WO2014084401A1 (ja) * 2012-11-30 2014-06-05 株式会社メディカルフロント 医用貼付剤
JP2016520656A (ja) * 2013-06-03 2016-07-14 トルマー，インコーポレイティド コルチコステロイド組成物
JP2017105837A (ja) * 2017-03-10 2017-06-15 株式会社メディカルフロント 医用貼付剤

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100439659B1 (ko) * 2001-06-23 2004-07-12 제일약품주식회사 툴로부테롤을 함유하는 경피흡수용 패취제
KR100535302B1 (ko) * 2002-02-01 2005-12-08 주식회사 태평양 툴로부테롤 함유 경피흡수형 제제
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
KR100511492B1 (ko) * 2002-10-11 2005-08-31 주식회사 태평양 에페리손, 톨페리손 또는 그것들의 염을 포함하는경피흡수제제
IL152573A (en) * 2002-10-31 2009-11-18 Transpharma Medical Ltd A system for the transmission through the skin of a medical preparation against vomiting and nausea
KR100397349B1 (en) * 2002-11-23 2003-09-13 Korea United Pharm Inc Solubilized aceclofenac, soft capsule using the same and manufacturing method thereof
GB0302662D0 (en) * 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron
WO2005046600A2 (en) * 2003-11-07 2005-05-26 Nexmed Holdings, Inc. Transdermal tulobuterol delivery
EP1685830A4 (de) * 2003-11-21 2010-04-28 Sekisui Chemical Co Ltd Pflaster
WO2006028863A1 (en) * 2004-09-01 2006-03-16 Nexmed Holdings, Inc. Transdermal antiemesis delivery system, method and composition therefor
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
EP1886675A4 (de) * 2005-06-01 2012-11-07 Nipro Patch Co Ltd Hautpflaster
US20070065494A1 (en) * 2005-08-03 2007-03-22 Watson Laboratories, Inc. Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
CN101296691B (zh) * 2005-08-05 2011-07-27 努沃研究公司 透皮释药剂型
US20070149916A1 (en) * 2005-12-22 2007-06-28 Alza Corporation Dry matrices as drug reservoirs in electrotransport applications
WO2007098591A2 (en) * 2006-03-02 2007-09-07 Nuvo Research Inc. Topical nail formulation
BRPI0717769A2 (pt) 2006-10-17 2013-11-05 Nuvo Res Formulação de gel, método para o tratamento da osteoartrite em um indivíduo sofrendo de dor articular, e, uso de diclofenac de sódio
US20080241231A1 (en) * 2007-02-21 2008-10-02 Victory Pharma, Incorporated Transdermal delivery of dexamethasone and promethazine
JP5224163B2 (ja) * 2007-07-24 2013-07-03 コスメディ製薬株式会社 経皮吸収テープ製剤
JP2009137925A (ja) * 2007-12-06 2009-06-25 Kosumedei Seiyaku Kk 経皮吸収テープ製剤及びその製造方法
US20090297590A1 (en) * 2008-05-30 2009-12-03 Masahiro Yamaji Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
CN102438597A (zh) * 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
KR101205186B1 (ko) 2010-06-04 2012-11-27 한불화장품주식회사 친수성 생리활성물질의 피부 투과를 촉진하는 화장료 조성물
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
CN107375251A (zh) * 2017-08-15 2017-11-24 徐静 一种含酮替芬的缓释透皮贴剂及其应用
WO2020118091A1 (en) * 2018-12-05 2020-06-11 Starton Therapeutics, Inc. Ondansetron in-adhesive transdermal patch

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02658A (ja) * 1987-10-15 1990-01-05 Dow Corning Corp 接着性組成物、調節された放出組成物、及び経皮性薬物供給装置
JPH03243680A (ja) * 1990-02-21 1991-10-30 Nippon Shokubai Kagaku Kogyo Co Ltd 親水性粘着剤組成物の製造方法
JPH10130145A (ja) * 1996-10-31 1998-05-19 Taisho Pharmaceut Co Ltd インドメタシン含有外用剤組成物
JPH10218793A (ja) * 1997-02-03 1998-08-18 Nichiban Co Ltd 経皮吸収型消炎鎮痛用テープ剤及びその製造方法
JPH10265379A (ja) * 1997-03-25 1998-10-06 Tanabe Seiyaku Co Ltd ドパミン誘導体含有経皮吸収型製剤
JPH11343248A (ja) * 1998-03-30 1999-12-14 Taisho Pharmaceut Co Ltd 局所タ―ゲティング用組成物
JP2001152031A (ja) * 1999-11-25 2001-06-05 Nippon Shokubai Co Ltd 親水性樹脂組成物および樹脂成形体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
US4616644A (en) * 1985-06-14 1986-10-14 Johnson & Johnson Products, Inc. Hemostatic adhesive bandage
US5035894A (en) * 1987-10-15 1991-07-30 Dow Corning Corporation Controlled release compositions and transdermal drug delivery device
US5252588A (en) * 1990-04-27 1993-10-12 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation
US5276079A (en) * 1991-11-15 1994-01-04 Minnesota Mining And Manufacturing Company Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
EP0737442A1 (de) * 1992-12-07 1996-10-16 Hisamitsu Pharmaceutical Co., Inc. Testpflaster und testmethode
KR100188180B1 (ko) * 1994-12-24 1999-06-01 서경배 경피투여용 패취제제
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
US6150459A (en) * 1998-04-13 2000-11-21 Massachusetts Institute Of Technology Comb polymers for regulating cell surface interactions
KR100332210B1 (ko) * 1998-12-04 2002-04-12 조민호 소염진통성분을 포함하는 경피투여 조성물 및 매트릭스형경피투여 패취제
KR100353428B1 (ko) * 1999-09-14 2002-09-18 히사미쯔세이야꾸가부시기가이샤 첩부제용 가소제 및 이 가소제를 함유하는 첩부제

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02658A (ja) * 1987-10-15 1990-01-05 Dow Corning Corp 接着性組成物、調節された放出組成物、及び経皮性薬物供給装置
JPH03243680A (ja) * 1990-02-21 1991-10-30 Nippon Shokubai Kagaku Kogyo Co Ltd 親水性粘着剤組成物の製造方法
JPH10130145A (ja) * 1996-10-31 1998-05-19 Taisho Pharmaceut Co Ltd インドメタシン含有外用剤組成物
JPH10218793A (ja) * 1997-02-03 1998-08-18 Nichiban Co Ltd 経皮吸収型消炎鎮痛用テープ剤及びその製造方法
JPH10265379A (ja) * 1997-03-25 1998-10-06 Tanabe Seiyaku Co Ltd ドパミン誘導体含有経皮吸収型製剤
JPH11343248A (ja) * 1998-03-30 1999-12-14 Taisho Pharmaceut Co Ltd 局所タ―ゲティング用組成物
JP2001152031A (ja) * 1999-11-25 2001-06-05 Nippon Shokubai Co Ltd 親水性樹脂組成物および樹脂成形体

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005170833A (ja) * 2003-12-10 2005-06-30 Nichiban Co Ltd 経皮吸収型貼付剤
JP2007536312A (ja) * 2004-05-07 2007-12-13 アンタレス ファルマ イーペーエル アクチェンゲゼルシャフト 抗コリン作用薬のための透過性増強組成物
JP2006151927A (ja) * 2004-12-01 2006-06-15 Toin Gakuen 光線力学的治療用組成物
WO2007119656A1 (ja) * 2006-04-11 2007-10-25 Nichiban Co., Ltd. タムスロシン含有経皮吸収型製剤
JP2009280509A (ja) * 2008-05-20 2009-12-03 Kowa Co 鎮痛・抗炎症剤含有外用剤
JP2010053078A (ja) * 2008-08-28 2010-03-11 Teika Seiyaku Kk オキシコドン経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤
WO2014084401A1 (ja) * 2012-11-30 2014-06-05 株式会社メディカルフロント 医用貼付剤
JP2014105205A (ja) * 2012-11-30 2014-06-09 Medical Front Co Ltd 医用貼付剤
JP2016520656A (ja) * 2013-06-03 2016-07-14 トルマー，インコーポレイティド コルチコステロイド組成物
JP2017105837A (ja) * 2017-03-10 2017-06-15 株式会社メディカルフロント 医用貼付剤

Also Published As

Publication number Publication date
EP1163902B1 (de) 2007-01-17
EP1163902A3 (de) 2002-11-06
KR100433614B1 (ko) 2004-05-31
US20020012695A1 (en) 2002-01-31
EP1163902A2 (de) 2001-12-19
DE60126017T2 (de) 2007-10-18
CN1171583C (zh) 2004-10-20
DE60126017D1 (de) 2007-03-08
KR20010113478A (ko) 2001-12-28
CN1329886A (zh) 2002-01-09

Similar Documents

Publication Publication Date Title
JP2002029965A (ja) 親水性または塩の形態よりなる薬物を含有する経皮投与用製剤
KR100275593B1 (ko) 경피 침투 강화제로써 트리아세틴
JP3489831B2 (ja) 活性成分パッチ
JPH11504038A (ja) ホルモンプラスター
EP0942697A1 (de) Fettsäureester von milchsäuresalzen als penetrationsförderer
JP2000502666A (ja) 外皮用エストラジオール／プロゲストゲン剤およびその製造方法
JP5111710B2 (ja) 安定化した過飽和経皮治療吸収基材システム
AU2007200426A1 (en) Transdermal delivery of lasofoxifene
JP2003528037A (ja) 気管支拡張剤ツロブテロールを皮膚から投与するための塩酸ツロブテロールを含む経皮治療システム
JP2006503877A (ja) エペリゾン、トルペリゾン又はそれらの塩を含む経皮製剤
JPH04217919A (ja) エペリゾンまたはトルペリゾン経皮吸収製剤
US20050100586A1 (en) Transdermal device for administering testosterone or one of the derivatives thereof
WO2012090322A1 (ja) 貼付剤
JPH07103016B2 (ja) 貼付剤およびその製造方法
JPH07116025B2 (ja) 貼付剤
JPH0753671B2 (ja) 経皮・経粘膜製剤
JPH09268123A (ja) 局所麻酔用貼付剤
JP3792305B2 (ja) 医療用粘着性組成物
CN111773201A (zh) 一种酚磺乙胺凝胶贴剂及其制备方法
WO2024067722A1 (zh) 含有秋水仙碱的贴剂及其制备方法和应用
JP2507068B2 (ja) 経皮吸収製剤
JP4235264B2 (ja) メシル酸プリジノール含有外用剤
JP3548195B2 (ja) 経皮吸収型製剤
JP2003534271A (ja) 活性物質の結晶化が減少された性質を有する経皮治療システム
AU724308B2 (en) Transdermal therapeutic systems that contain sex steroids

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050119

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050622